Adult Lineage-Restricted CNS Progenitors Specify Distinct Glioblastoma Subtypes.
暂无分享,去创建一个
Euiseok J. Kim | D. Burns | J. Xu | L. Parada | J. Raisanen | K. Hatanpaa | Jane E. Johnson | Jian Chen | Zilai Wang | Daochun Sun | Sheila Alcantara Llaguno | Jing Xu
[1] R. Verhaak,et al. Transformation of quiescent adult oligodendrocyte precursor cells into malignant glioma through a multistep reactivation process , 2014, Proceedings of the National Academy of Sciences.
[2] S. Morrison,et al. Prospective identification of functionally distinct stem cells and neurosphere-initiating cells in adult mouse forebrain , 2014, eLife.
[3] Krystal M. Straessler,et al. Modeling clear cell sarcomagenesis in the mouse: cell of origin differentiation state impacts tumor characteristics. , 2013, Cancer cell.
[4] Eric A Bushong,et al. Dedifferentiation of Neurons and Astrocytes by Oncogenes Can Induce Gliomas in Mice , 2012, Science.
[5] Jun Z. Li,et al. Genomic Estimates of Aneuploid Content in Glioblastoma Multiforme and Improved Classification , 2012, Clinical Cancer Research.
[6] Zhiguo Zhao,et al. Cell of Origin Determines Tumor Phenotype in an Oncogenic Ras/p53 Knockout Transgenic Model of High-Grade Glioma , 2012, Journal of neuropathology and experimental neurology.
[7] Lynda Chin,et al. Emerging insights into the molecular and cellular basis of glioblastoma. , 2012, Genes & development.
[8] L. Parada,et al. Malignant Glioma: Lessons from Genomics, Mouse Models, and Stem Cells , 2012, Cell.
[9] L. Luo,et al. Mosaic Analysis with Double Markers Reveals Tumor Cell of Origin in Glioma , 2011, Cell.
[10] Xiaoqin Zhu,et al. Age-dependent fate and lineage restriction of single NG2 cells , 2011, Development.
[11] Jane E. Visvader,et al. Cells of origin in cancer , 2011, Nature.
[12] Magdalena Götz,et al. In vivo fate mapping and expression analysis reveals molecular hallmarks of prospectively isolated adult neural stem cells. , 2010, Cell stem cell.
[13] S. Sell. On the stem cell origin of cancer. , 2010, The American journal of pathology.
[14] A. Álvarez-Buylla,et al. Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypes , 2010, The EMBO journal.
[15] Arnold Kriegstein,et al. The glial nature of embryonic and adult neural stem cells. , 2009, Annual review of neuroscience.
[16] L. Parada,et al. Inducible site‐specific recombination in neural stem/progenitor cells , 2009, Genesis.
[17] Arturo Alvarez-Buylla,et al. Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. , 2009, Cancer cell.
[18] Euiseok J. Kim,et al. Ascl1 (Mash1) lineage cells contribute to discrete cell populations in CNS architecture , 2008, Molecular and Cellular Neuroscience.
[19] Santosh Kesari,et al. Malignant gliomas in adults. , 2008, The New England journal of medicine.
[20] R. Mason,et al. Pten haploinsufficiency accelerates formation of high-grade astrocytomas. , 2008, Cancer research.
[21] F. Gage,et al. Mechanisms and Functional Implications of Adult Neurogenesis , 2008, Cell.
[22] Y. Xing,et al. A Transcriptome Database for Astrocytes, Neurons, and Oligodendrocytes: A New Resource for Understanding Brain Development and Function , 2008, The Journal of Neuroscience.
[23] Euiseok J. Kim,et al. In Vivo Analysis of Ascl1 Defined Progenitors Reveals Distinct Developmental Dynamics during Adult Neurogenesis and Gliogenesis , 2007, The Journal of Neuroscience.
[24] B. Scheithauer,et al. The 2007 WHO Classification of Tumours of the Central Nervous System , 2007, Acta Neuropathologica.
[25] T. Golub,et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9 , 2006, Nature.
[26] Thomas D. Wu,et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.
[27] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[28] Mitchel S Berger,et al. Neural stem cells and the origin of gliomas. , 2005, The New England journal of medicine.
[29] Dawen Zhao,et al. Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. , 2005, Cancer cell.
[30] P. Kleihues,et al. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. , 2005, Journal of neuropathology and experimental neurology.
[31] Martin J. van den Bent,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[32] K. Akashi,et al. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. , 2004, Cancer cell.
[33] A. Álvarez-Buylla,et al. For the Long Run Maintaining Germinal Niches in the Adult Brain , 2004, Neuron.
[34] I. Weissman,et al. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. , 2003, Genes & development.
[35] Daniel A. Lim,et al. Subventricular Zone Astrocytes Are Neural Stem Cells in the Adult Mammalian Brain , 1999, Cell.
[36] L. Lillien. Neural progenitors and stem cells: mechanisms of progenitor heterogeneity , 1998, Current Opinion in Neurobiology.
[37] Tzong-Shiue Yu,et al. A restricted cell population propagates glioblastoma growth after chemotherapy , 2012 .
[38] Yuan Qi,et al. Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA , IDH 1 , EGFR , and NF 1 Citation Verhaak , 2010 .
[39] V. Preedy,et al. European Organization for Research and Treatment of Cancer , 2010 .
[40] A. Nishiyama,et al. Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity , 2009, Nature Reviews Neuroscience.
[41] Amy E. Hawkins,et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2022 .
[42] J. Mesirov,et al. An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis , 2005, Nature Genetics.
[43] Zang Ai-hua,et al. Stem Cells,Cancer and Cancer Stem Cells , 2005 .